All In MedTech

Device Trial Radar · NCT06008080

Post-Market Clinical Follow Up Study With Navitor Valve

VISTA Nova Study (Navitor Post-Market Clinical Follow Up Study)

Last checked: Nov 20, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Sep 29, 2023

Primary completion

Jul 2027

Study completion Jun 2032

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Aug 23, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the safety and performance of the Navitor TAVI System in a Global Study

Conditions

  • Aortic Stenosis

Interventions

  • Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading SystemDevice

    Subjects will undergo transcatheter aortic valve replacement (TAVR) with the Navitor valve, the FlexNav Delivery system and the Navitor Loading System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause mortality at 30 days post-TAVI procedureTime frame: 30 days post index procedure
  2. Moderate or greater paravalvular leak at 30 days post-TAVI procedureTime frame: 30 days post index procedure

Locations

50 sites in 11 countries. Site status is shown where the registry gives one.

  • Royal Adelaide Hospital

    Adelaide, Australia · Recruiting

  • Royal Hobart Hospital

    Hobart, Australia · Recruiting

  • The Alfred Hospital

    Melbourne, Australia · Recruiting

47 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.